Lpl Financial LLC Revance Therapeutics, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 42,905 shares of RVNC stock, worth $110,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,905

Previous 50,125 14.4%

Holding current value

$110,265

Previous $128,000 14.06%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$2.57 - $2.57 $18,555 - $18,555	-7,220 Reduced 14.4%	42,905 $110,000
Q2 2024 Aug 07, 2024	BUY	$2.34 - $4.73 $4,988 - $10,084	2,132 Added 4.44%	50,125 $128,000
Q1 2024 May 10, 2024	BUY	$4.65 - $9.31 $40,901 - $81,890	8,796 Added 22.44%	47,993 $236,000
Q4 2023 Feb 14, 2024	BUY	$5.81 - $11.2 $95,301 - $183,713	16,403 Added 71.96%	39,197 $344,000
Q3 2023 Nov 13, 2023	SELL	$11.47 - $25.07 $11,217 - $24,518	-978 Reduced 4.11%	22,794 $261,000
Q2 2023 Jul 31, 2023	BUY	$24.7 - $37.61 $34,234 - $52,127	1,386 Added 6.19%	23,772 $601,000
Q1 2023 May 10, 2023	BUY	$18.36 - $35.27 $153,544 - $294,963	8,363 Added 59.64%	22,386 $721,000
Q4 2022 Feb 07, 2023	SELL	$18.32 - $30.66 $244,040 - $408,421	-13,321 Reduced 48.72%	14,023 $258,000
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $200,634 - $398,608	14,001 Added 104.93%	27,344 $738,000
Q2 2022 Aug 12, 2022	BUY	$11.52 - $20.4 $35,596 - $63,035	3,090 Added 30.14%	13,343 $184,000
Q1 2022 May 16, 2022	BUY	$12.36 - $20.31 $126,727 - $208,238	10,253 New	10,253 $200,000
Q4 2021 Feb 14, 2022	SELL	$12.46 - $27.87 $241,063 - $539,200	-19,347 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$25.78 - $33.21 $175,432 - $225,994	-6,805 Reduced 26.02%	19,347 $539,000
Q2 2021 Aug 13, 2021	SELL	$26.8 - $31.84 $89,565 - $106,409	-3,342 Reduced 11.33%	26,152 $775,000
Q1 2021 May 14, 2021	SELL	$24.03 - $29.97 $35,972 - $44,865	-1,497 Reduced 4.83%	29,494 $824,000
Q4 2020 Feb 12, 2021	SELL	$23.41 - $28.34 $231,595 - $280,367	-9,893 Reduced 24.2%	30,991 $878,000
Q3 2020 Nov 09, 2020	BUY	$23.23 - $34.3 $27,643 - $40,817	1,190 Added 3.0%	40,884 $1.03 Million
Q2 2020 Aug 13, 2020	BUY	$12.6 - $26.55 $500,144 - $1.05 Million	39,694 New	39,694 $969,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Revance Therapeutics, Inc. Transaction History